Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci

Infection and Immunity

Volumn 64, Issue 12, 1996, Pages 5042-5046

  Vallejo, Jesus G ^a   Baker, Carol J ^a   Edwards, Morven S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; SEPTIC SHOCK; STREPTOCOCCUS AGALACTIAE; UMBILICAL CORD BLOOD;

EID: 0029828759     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.12.5042-5046.1996     Document Type: Article

References (42)

1. Baker, C. J., and M. S. Edwards. 1995. Group B streptococcal infections, p. 980-1054. in J. S. Remington and J. O. Klein (ed), Inf'ectious diseases of the fetus and newborn infant, 4th ed. W. B. Saunders Co., Philadelphia,
2. Baker, C, J., M. S, Edwards, and D. L. Kasper. 1981. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics 68:544-549.
3. Baker, C, J., and D. L, Kasper. 1976. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N. Engl. J. Med. 294:753-756.
4. Baker, C. J., and D. L. Kasper. 1977. Immunological investigation of infants with septiccmia or meningitis due to group B Streptococcus. J. Infect, Dis. 136:S98-S104.
5. Baker, C. J, B. J. Webb, C. V. Jackson, and M. S. Edwards. 1986. Countcrcurrcnt immunoclectrophorcsis in the evaluation of infants with group B streptococcal disease. J. Pediatr. 154:47-54.
6. Bhakdi, S., T. Klonisch, P. Nuber, and W, Fischer, 1991. Stimulation of monokine production by lipoteichoic acids. Infect. Immun. 59:4614-4621.
7. Bone, R. C, 1994. Gram-positive organisms and sepsis. Arch. Intern. Med. 154:26-34.
8. Casey, R. B., R. A. Balk, and R, C. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119:771-778.
9. De Cuenlnck, B. J., G. D. Shockman. and R. M. Swenson. 1982. Group B, type III streptococcal cell wall: composition and structural aspects revealed through endo-N-acetylmuramidase-catalyzed hydrolysis. Infect. Immun. 35: 572-582.
10. Dulkerlan, S. J., L. Kilpatrick, A. T, Castarino, L. McCauley, J. Fein, L. Corcoran, S. Zirin, and M. C, Harris. 1995. Cytokine elevations in infants with bacterial and aseptic meningitis. J, Pediatr. 126:872-876,
11. Gibson, R. L., G. J. Redding, W. R. Henderson, and W. E. Truog. 1991. Group B Streptococcus induces tumor necrosis factor in neonatal piglets. Am. Rev. Respir, Dis. 143:598-604.
12. Givner, L. B., L Gray, and T. M. O'Shea. 1995. Antibodies to tumor necrosis factor-a: use as adjunctivc therapy in established group B streptococcal disease in newborn ruts. Pediatr. Res, 38:551-554.
13. Heumann, D., C. Barras, A. Severln, M. P, Glauser, and A. Tomasz. 1994. Gram-positive cell walls stimulate synthesis of tumor necrosis alpha and interleukin-6 by human monocytes. Infect. Immun. 62:2715-2721.
14. Ling, E. W. Y., F. D. J. Noya, G. Ricard, K. Beharry, E, L. Mills, and J. V. Aranda. 1995, Biochemical mediators of meningeal inflammatory response to group B Streptococcus in the newborn piglet model. Podiatr. Res. 38:981-987.
15. Lancefield, R. C., M. McCarty, and W, Everly. 1975. Multiple mouse-protective antibodies directed against group B streptococci. J. Exp. Med. 142: 165-179.
16. Mancuso, G., F. Tomasello, T. Ofek, and G. Teli. 1994. Antilipoteichoic acid antibodies enhance release of cytokines by monocytes sensitized with lipoteiechoic acid. Infect Immun, 62:1470-1473,
17. Mancuso, G., F. Tomaselln, C. von Hunolstein, G, Oreflcl. and G. Tetl. 1994. Induction of tumor necrosis factor alpha by the group- and type-specific polysaechnrides from type III group B streptococci. Infect. Immun. 62:2748-2753.
18. Marks, J. D., C, B. Marks, J. M. Luce. A, B. Montgomery, J. Turner, C. A. Metz, and J. F. Murray. 1990. Plasma tumor necrosis factor in patients with septic shock. Am. Rev. Respir. Dis. 141:94-97.
19. Marques, M. B., D. L. Kasper, M. K. Pangburn, and M. R. Wessels, 1992. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect. Immun. 60:3986-3993.
20. Mattingiy, S. J., and B. P. Johnston. 1987. Comparative analysis and localization of lipoteiehoic acid in Streptococcus agalactiae and Streptococcus Pyogenes. Infect. Immun. 55:2383-2386.
21. Mnttsson, E., J. Rollof, J. Verhoef, V. H. Dijk, and A. Fleer. 1994. Seruminduced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infeet, Immun. 62:3837-3843.
22. Mattsson, E., H. Van Dljk. K. V. Kessel, J. Verhoef, A. Fleer, and J. Rollof. 1996, Intracellular pathways of tumor necrosis factor-α release by human monocytes on stimulation with lipopolysaccharide or staphylococcal peptidoglycan are partly similar. J. Infect. Dis. 173:212-218.
23. Michon, F., E. Katzenellenbogen, D. L. Kasper, and H. L. Jennings. 1987. Structure of the complex group-specific polysaccharide of group B Streptococcus, Biochemistry 26:476-486.
24. Musher, D. M., H. Verbrugh, and J. Verhoef. 1981. Suppression of phagocytosis and chemotaxis by cell wall components of Staphylococcus aureus. J, Immunol. 127:84-88.
25. Nenlon, T. J., and S, J. Mattingly. 1985. Kinetic and chemical analysis of the biologic significance of lipoteichoic acids mediating adherence of serotype III group B streptococci, Infect. Immun. 50:107-115.
26. Payne, N. R., B. A. Burke, D. L. Day, P. D. Christenson, T. R. Thompson, and P. Ferrleri. 1988. Correlation of clinical and pathologic findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome. Pediatr. Infect. Dis. J. 7:836-847.
27. Peat, E. B., N. H. Augustine, W. K. Drummond, J. F. Bohnsack, and H. R. Hill. 1995. Effects of fibronectin and group B streptococci on tumor necrosis factor-α production by human cultured-derived macrophages. Immunology 84:440-445.
28. Peterson, P. K., B. J. Wilklnson, Y. Kirn. D. Schmeling, S. D, Douglas, P. G. Qule, and J. Verhoef. 1978. The key role of peptidoglycan in the opsonization of Staphylococcus. J. Clin. Invest. 61:597-619.
29. Rubens, C. E., J. M. Kupers, L. M. Heggen, D. L Kasper, and M. R. Wessels. 1991, Molecular analysis of the group B streptococcal capsule genes, p. 179-183. In G. M. Dunny. P. P. Clcary. and L. L. McKay (ed.), Genetics and molecular biology of streptococci, luctococci, and enterococci. American Suciety for Microbiology. Washington, D.C.
30. Tetl, G., G. Mancuso, and F, Tomasello. 1993. Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcil infection. Infect. Immun. 61:227-235.
31. Teti, G.,G. Mancuso, F. Tomasello. and M. S. Chiofalo. 1992. Production of tumor necrosis factor-α and interleukin-6 in mice infected with group B streptococci. Circ. Shock 38:138-144.
32. Timmerman, C. P., E. Mattsson, L. Martinez-Martinez, L, De Graaf, J. A. E. VanStrijp, H. A. Verbrugh, J. Verhoef, and A. Fleer. 1995. Induction of release of tumor necrosis factor from human monocytes by staphylococci and stuphylococcal peptidoglycan. Infect. Immun. 61:4167-4172.
33. Tuomanen, E., H. Llu, B. Hengstler, O. Zak, and A. Tomasz. 1985. The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151:859-868.
34. Tuomanen, E., K. Rich, and O. Zak. 1986. Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am. Rev, Respir. Dis. 135:869-874.
35. Tuomanen, E., A. Tomasz, B. Hengstler, and O. Zak. 1985. The relative role of huctcrial cull wall and capsule in the induction of inflammation in pneumococcal meningitis. J. Infect. Dis. 151:535-540.
36. 35a.ValleJo, J. C., C. J. Baker, M. S. Edwards. 1995. The group B cell wall antigen of group B Streptococcus induces tumor necrosis factor alpha production by human neonatal monocytes. Clin. Infect. Dis. 21:806. (Abstract.)
37. Verbrugh, H., W. Van Dyk, R. Peters, M. Van der Tol, and J. Verhoef. 1979. The role of Slaphylococcus aureus cell-wall peptidoglycan, teichoic acid, and protein A in the processes of complement activation and opsonization. Immunology 37:615-621.
38. Waage, A., P. Brandlzaeg, T. Espevik, and A. Halstensen. 1991. Current understanding of the pathogcncsis of gram-negative shock. Infect. Dis. Clin. North Am. 5:781-791.
39. Wakabayashl, G., J, A. Gelfand, W. K. Jung, R. J. Conolly, J. F. Burke, and C. A. Dinarello. 1991. Staphylococcus epidemidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. J. Clin. Invest. 87:1925-1935.
40. Weldemann. B., H. Brade, E. T. Rietschel, R. Dziarski, V. Bazil, S. Kusumoto, H.-D. Flad, and J. Ulmer. 1994. Soluble peptidoglycan-induced monokinu production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect. Immun. 62:4709-4715.
41. Wessels, M. R., L. C. Paoletti, D. L. Kasper, J. L. DiFabio, F. Michon, and H. J. Jenntngs. 1990. Immunogenicity in animals of a polysaccharidc-protrein conjugate vaccine against type III group B Streptococcus. J. Clin. Invest. 86:1428-1433.
42. Williams, P. A., J. F. Bohnsack, N. H. Augustine, W. K. Drummond, C. E. Rubens, and H. R. Hill. 1993. Production of tumor necrosis factor by human cell in vitro and in vivo, induced by group B streptococci. J. Pedintr. 123: 292-300,